VELAN CAPITAL, L.P. purchased 7.0% of their position (521.04K shares) of PROGENICS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $2.32M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/5/2019ACC: 0000921895-19-002367
10% OwnerOther
Since Aug 2019
+521.04K
Net shares
Net buyer
$2.32M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
521.04K acquired
Non-Derivative Transactions2
Common Stock, $0.0013 par value
Direct
Shares
+277.42K
Price / share
$4.39
Trade value
$1.22M
% of position
3.7%
9/3/2019
7.42M→7.70M
Common Stock, $0.0013 par value
Direct
Shares
+243.61K
Price / share
$4.51
Trade value
$1.10M
% of position
3.2%
9/4/2019
7.70M→7.94M
Total
Net shares
+521.04K
Net value
$2.32M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0013 par value Direct | 9/3/2019 | P · Purchase | +277.42K | $4.39 | $1.22M | 3.7% | 7.42M | 7.70M |
| Common Stock, $0.0013 par value Direct | 9/4/2019 | P · Purchase | +243.61K | $4.51 | $1.10M | 3.2% | 7.70M | 7.94M |
| Total | +521.04K | $2.32M | ||||||
Derivative Transactions0
No derivative transactions reported